NASDAQ : EUCR

Eucrates Biomedical Acquisition Corp. — Institutional Ownership

$10.04 USD

$0 (0.0%)

Volume
12.7K
Average Volume
1.66K
Market Capitalization
$42.23M
P/E Ratio
5.40
Dividend Yield
0.00%
Price Target
Year High
$10.25
Year Low
$9.87
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.03
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2022-11-09 (1) BlackRock, Inc. - 0.00%
2022-02-14 52-0556948 730.86K 5.40%
2021-02-12 Eucrates LLC 2.62M 19.50%
2021-02-12 Parag Saxena 2.62M 19.50%
2021-02-12 Stelios Papadopoulos 2.62M 19.50%
2020-10-30 Deerfield Partners, L.P. 1M 7.78%
2020-10-30 Company, L.P. 1M 7.78%
2020-10-30 James E. Flynn 1M 7.78%
2020-10-30 Deerfield Mgmt, L.P. 1M 7.78%
EUCR Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2022-12-31 $9.99 2.98M $29.76M $18865 $60060 $29.8M
2021-12-31 $9.76 2.98M $29.08M $49156 -$ $29.03M
2020-12-31 $10.05 13.46M $135.26M $551.26K -$ $134.71M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2022-12-31 $9.99 2.98M $29.76M $18865 $60060 $29.8M
2022-09-30 $10.02 10.48M $105.01M $60044 $62870 $105.01M
2022-06-30 $9.90 10.48M $103.75M $104.77K $186.9K $103.83M
2022-03-31 $9.84 2.98M $29.31M $159.07K $185.7K $29.34M
2021-12-31 $9.76 4.21M $41.13M $49156 -$ $41.08M
2021-09-30 $9.78 2.98M $29.13M $206.22K -$ $28.93M
2021-06-30 $9.85 4.21M $41.49M $383.23K -$ $41.1M
2021-03-31 $9.98 4.41M $44.03M $443.25K -$ $43.59M
2020-12-31 $10.05 4.41M $44.34M $551.26K -$ $43.79M
2020-09-30 $10.00 - -$ -$ -$ -$